Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. Summary
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
Delayed Quote. Delayed Swiss Exchange - 12/03 11:30:38 am
73.57 CHF   -0.31%
09:40aBryan Garnier Downgrades Novartis to Neutral from Buy
MT
07:17aNOVARTIS AG : UBS reaffirms its Neutral rating
MD
06:30aNOVARTIS AG : Sell rating from JP Morgan
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Novartis : Unit Closes Purchase of GlaxoSmithKline's Cephalosporin Antibiotics Business

10/11/2021 | 04:10am EST


© MT Newswires 2021
All news about NOVARTIS AG
09:40aBryan Garnier Downgrades Novartis to Neutral from Buy
MT
07:17aNOVARTIS AG : UBS reaffirms its Neutral rating
MD
06:30aNOVARTIS AG : Sell rating from JP Morgan
MD
03:19aDrugmakers cut prices by 62% on average to get China state insurance listing
RE
12/02Novartis Mulls Bolt-On Acquisitions
CI
12/02GLOBAL MARKETS LIVE : Hermès, Walt Disney, Apple, Novartis, Square...
12/02MarketScreener's World Press Review - December 2, 2021
12/02Novartis Sees 4% Compound Annual Growth in Sales Through 2026
MT
12/02EUROPEAN MIDDAY BRIEFING - Stocks Tumble Again in -2-
DJ
12/02NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
DJ
More news
Analyst Recommendations on NOVARTIS AG
More recommendations
Financials (USD)
Sales 2021 52 117 M - -
Net income 2021 15 146 M - -
Net Debt 2021 20 532 M - -
P/E ratio 2021 11,6x
Yield 2021 4,47%
Capitalization 165 B 179 B -
EV / Sales 2021 3,55x
EV / Sales 2022 3,34x
Nbr of Employees 108 000
Free-Float 85,7%
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 73,57 $
Average target price 97,48 $
Spread / Average Target 32,5%
EPS Revisions
Managers and Directors
Vasant Narasimhan Chief Executive Officer
Harry Werner Kirsch Chief Financial Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
John Tsai Chief Medical Officer
Klaus Moosmayer Chief Ethics Risk & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
NOVARTIS AG-11.78%179 510
JOHNSON & JOHNSON-0.18%413 555
ROCHE HOLDING AG17.62%341 509
PFIZER, INC.44.09%297 706
NOVO NORDISK A/S64.51%243 534
ELI LILLY AND COMPANY47.55%224 726